Nicole G Hansbro Selected Research

Therapeutics

12/2023	Characterization and inhibition of inflammasome responses in severe and non-severe asthma.
2/2021	Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators.
1/2021	Human β-defensin-2 suppresses key features of asthma in murine models of allergic airways disease.
1/2019	Microbiome-focused asthma management strategies.
1/2017	Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma.
1/2017	Role for NLRP3 Inflammasome-mediated, IL-1β-Dependent Responses in Severe, Steroid-Resistant Asthma.
1/2017	MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases.
3/2013	A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicole G Hansbro Research Topics

Disease

17	Asthma (Bronchial Asthma) 12/2023 - 02/2008
16	Inflammation (Inflammations) 08/2023 - 02/2008
10	Chronic Obstructive Pulmonary Disease (COPD) 11/2023 - 01/2010
9	Infections 01/2022 - 09/2007
6	Airway Remodeling 01/2023 - 03/2013
6	Respiratory Hypersensitivity 01/2021 - 02/2008
5	COVID-19 03/2023 - 11/2021
4	Neoplasms (Cancer) 12/2023 - 03/2020
4	Lung Neoplasms (Lung Cancer) 12/2023 - 11/2020
4	Emphysema 11/2023 - 03/2013
4	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017 - 01/2017
3	Virus Diseases (Viral Diseases) 01/2023 - 07/2013
2	Carcinogenesis 08/2023 - 02/2023
2	Lung Diseases (Lung Disease) 01/2023 - 01/2017
2	Pneumonia (Pneumonitis) 01/2023 - 12/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2023
1	Neoplasm Metastasis (Metastasis) 12/2023
1	Adenocarcinoma of Lung 12/2023
1	Respiratory Insufficiency (Respiratory Failure) 03/2023
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 03/2023
1	Thromboinflammation 01/2023
1	Carcinoma (Carcinomatosis) 07/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2021
1	Hypertrophy 02/2021
1	Lung Injury 01/2021
1	Infection with Mycobacterium marinum 12/2020
1	Colonic Neoplasms (Colon Cancer) 03/2020
1	Colorectal Neoplasms (Colorectal Cancer) 03/2020

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 12/2023 - 12/2017
8	SmokeIBA 11/2023 - 03/2013
8	CytokinesIBA 12/2022 - 09/2007
7	SteroidsIBA 01/2021 - 01/2017
5	OvalbuminIBA 01/2021 - 09/2007
5	Interleukin-13IBA 01/2021 - 02/2008
4	Messenger RNA (mRNA)IBA 11/2023 - 01/2019
4	CollagenIBA 02/2021 - 01/2010
4	MicroRNAs (MicroRNA)IBA 01/2018 - 07/2013
3	CateninsIBA 12/2023 - 02/2023
3	VaccinesIBA 01/2022 - 01/2016
3	AllergensIBA 02/2021 - 03/2013
3	Interleukin-5 (Interleukin 5)IBA 12/2017 - 09/2007
2	InflammasomesIBA 12/2023 - 01/2017
2	Monoclonal AntibodiesIBA 11/2023 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
2	Peptide Hydrolases (Proteases)FDA Link 12/2022 - 01/2022
2	COVID-19 VaccinesIBA 01/2022 - 11/2021
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2019
2	Immunoglobulin E (IgE)IBA 01/2021 - 02/2008
2	Peptides (Polypeptides)IBA 03/2020 - 01/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2017
2	Extracellular Matrix ProteinsIBA 12/2017 - 10/2010
2	type IV collagen alpha3 chain (Goodpasture antigen)IBA 01/2014 - 01/2010
2	AntigensIBA 07/2013 - 09/2007
1	NigericinIBA 12/2023
1	isoquinolineIBA 12/2023
1	BerberineIBA 12/2023
1	AlkaloidsIBA 12/2023
1	Imiquimod (Aldara)FDA LinkGeneric 11/2023
1	Mast Cell StabilizersIBA 11/2023
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 11/2023
1	Toll-Like Receptor 7IBA 11/2023
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2023
1	Biomarkers (Surrogate Marker)IBA 03/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Pancreatic Elastase (Elastase)IBA 01/2023
1	Thrombin FDA Link 01/2023
1	Protein Kinases (Protein Kinase)IBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	MRT67307IBA 01/2023
1	Interferon Type IIBA 01/2023
1	Sulfalene (Longum)IBA 12/2022
1	Butyrates (Butyrate)IBA 12/2022
1	Acetates (Acetic Acid Esters)FDA Link 12/2022
1	protease SIBA 12/2022
1	Chymases (Chymase)IBA 12/2022
1	SerpinsIBA 01/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	Rutin (Rutoside)IBA 07/2021
1	Bronchodilator Agents (Bronchodilators)IBA 01/2021
1	DefensinsIBA 01/2021
1	Methacholine Chloride (Methacholine)FDA Link 01/2021
1	Interleukin-9 (Interleukin 9)IBA 01/2021
1	CurcuminIBA 12/2020
1	Lipid NanoparticlesIBA 12/2020
1	Liposomes (Liposome)IBA 12/2020
1	ChitosanIBA 11/2020
1	boswellic acidIBA 11/2020
1	Recombinant ProteinsIBA 03/2020
1	Culture MediaIBA 03/2020
1	ElastinIBA 03/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2020
1	Interleukin-27 (Interleukin 27)IBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	EndotoxinsIBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Blocking AntibodiesIBA 01/2020

Therapy/Procedure

8	Therapeutics 12/2023 - 03/2013
1	Mechanical Ventilators (Ventilator) 03/2023
1	Ligation 01/2021